Enanta Pharmaceuticals, Inc. ENTA | $36.58M | 9.89 | 2.1M | +3.46% | +$1.22M | 0.26 | |
Agios Pharmaceuticals, Inc. AGIO | $163.47M | 9.85 | 5.59M | +34.14% | +$41.61M | 1.15 | |
Protagonist Therapeutics, Inc. PTGX | $166.03M | 9.79 | 5.74M | +0.08% | +$131,428.99 | 1.17 | |
Exelixis, Inc. EXEL | $633.08M | 9.16 | 26.68M | +0.17% | +$1.04M | 4.45 | |
Longboard Pharmaceuticals, Inc. LBPH | $63.51M | 7.56 | 2.94M | +88.43% | +$29.81M | 0.45 |